- Report
- June 2024
- 200 Pages
Global
From €7559EUR$7,950USD£6,356GBP
- Report
- January 2022
- 60 Pages
Global
From €3756EUR$3,950USD£3,158GBP
Goitre is a condition in which the thyroid gland enlarges, resulting in a swelling in the neck. Goitre is a common endocrine disorder, and is typically treated with drugs that target the thyroid gland. These drugs are part of the Endocrine and Metabolic Disorders Drugs market, which also includes drugs for diabetes, obesity, and other endocrine disorders.
Goitre drugs are typically used to reduce the size of the thyroid gland, and to regulate the production of hormones. These drugs can be administered orally, intravenously, or topically. Commonly prescribed drugs for goitre include levothyroxine, liothyronine, and methimazole.
The Endocrine and Metabolic Disorders Drugs market is a large and growing market, with many companies offering drugs for goitre and other endocrine disorders. Some of the major players in this market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more